{{Rsnum
|rsid=1045570
|Gene=RXRA
|Chromosome=9
|position=134440465
|Orientation=plus
|GMAF=0.1552
|Gene_s=RXRA
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 66.4 | 32.7 | 0.9
| HCB | 60.6 | 36.5 | 2.9
| JPT | 69.0 | 25.7 | 5.3
| YRI | 100.0 | 0.0 | 0.0
| ASW | 82.5 | 17.5 | 0.0
| CHB | 60.6 | 36.5 | 2.9
| CHD | 66.1 | 30.3 | 3.7
| GIH | 54.5 | 39.6 | 5.9
| LWK | 0.0 | 0.0 | 0.0
| MEX | 55.2 | 39.7 | 5.2
| MKK | 91.7 | 8.3 | 0.0
| TSI | 72.5 | 26.5 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22475777
|Title=Association Between PPAR-? and RXR-? Gene Polymorphism and Metabolic Syndrome Risk: A Case-Control Study of a Chinese Han Population
}}

{{PMID Auto
|PMID=16600026
|Title=Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway.
|OA=1
}}

{{PMID Auto
|PMID=22023374
|Title=Application of back propagation artificial neural network on genetic variants in adiponectin ADIPOQ, peroxisome proliferator-activated receptor-gamma, and retinoid X receptor-alpha genes and type 2 diabetes risk in a Chinese Han population.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}